| RVMDREVOLUTION MEDICINES, INC. | 5,475,611 | $532.5M |
| CNTACentessa Pharmaceuticals plc | 8,925,010 | $354.5M |
| ROIVRoivant Sciences Ltd. | 12,794,097 | $354.4M |
| TNGXTango Therapeutics, Inc. | 12,809,485 | $268.0M |
| INSMINSMED Inc | 900,000 | $147.2M |
| GILDGILEAD SCIENCES, INC. | 916,513 | $127.7M |
| AXSMAxsome Therapeutics, Inc. | 737,578 | $124.7M |
| TERNTerns Pharmaceuticals, Inc. | 2,124,817 | $112.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 103,097 | $79.7M |
| NUVLNuvalent, Inc. | 748,896 | $76.7M |
| MANEVeradermics Incorporated | 1,100,000 | $69.5M |
| ARGXARGENX SE | 90,000 | $65.7M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 725,744 | $63.1M |
| CMPXCompass Therapeutics, Inc. | 8,486,500 | $44.9M |
| ABVXAbivax SA | 400,539 | $44.6M |
| BBIOBridgeBio Pharma, Inc. | 599,000 | $44.5M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 1,106,631 | $35.4M |
| MAZEMaze Therapeutics, Inc. | 1,178,000 | $35.2M |
| SRRKScholar Rock Holding Corp | 700,000 | $34.4M |
| RLMDRELMADA THERAPEUTICS, INC. | 4,763,158 | $33.2M |
| PTGXProtagonist Therapeutics, Inc | 282,436 | $29.8M |
| TVTXTravere Therapeutics, Inc. | 977,000 | $29.0M |
| IRDOpus Genetics, Inc. | 6,029,775 | $27.4M |
| RLAYRelay Therapeutics, Inc. | 2,590,000 | $25.8M |
| FBRXForte Biosciences, Inc. | 950,000 | $24.6M |
| FOLDAMICUS THERAPEUTICS, INC. | 1,650,000 | $23.9M |
| ANNXAnnexon, Inc. | 4,300,000 | $23.8M |
| KODKodiak Sciences Inc. | 575,000 | $21.9M |
| DFTXDefinium Therapeutics Inc. | 1,150,000 | $21.7M |
| APGEApogee Therapeutics, Inc. | 250,000 | $21.0M |
| PCVXVaxcyte, Inc. | 350,000 | $20.3M |
| ATAIAtai Beckley N.V. | 5,642,758 | $20.0M |
| VRDNViridian Therapeutics, Inc.\DE | 970,018 | $19.0M |
| ZURAZura Bio Ltd | 2,750,000 | $16.4M |
| FDMT4D Molecular Therapeutics, Inc. | 1,605,156 | $14.9M |
| OVIDOvid Therapeutics Inc. | 6,163,781 | $13.7M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 160,000 | $13.4M |
| SABSSAB BIOTHERAPEUTICS, INC. | 3,405,553 | $13.0M |
| AVTXAvalo Therapeutics, Inc. | 854,000 | $12.8M |
| BHVNBiohaven Ltd. | 1,497,793 | $12.7M |
| SLDBSolid Biosciences Inc. | 1,756,506 | $12.6M |
| ABUSArbutus Biopharma Corp | 2,664,941 | $12.0M |
| IMVTImmunovant, Inc. | 413,000 | $10.3M |
| PRQRProQR Therapeutics N.V. | 6,253,467 | $10.1M |
| ORKAOruka Therapeutics, Inc. | 190,030 | $9.3M |
| BIOABioAge Labs, Inc. | 500,000 | $8.7M |
| CAMPCamp4 Therapeutics Corp | 1,960,784 | $8.6M |
| TENXTENAX THERAPEUTICS, INC. | 540,126 | $8.6M |
| ARQTArcutis Biotherapeutics, Inc. | 366,000 | $8.6M |
| SIONSionna Therapeutics, Inc. | 150,000 | $6.0M |
| OKUROnKure Therapeutics, Inc. | 1,204,819 | $5.0M |
| STROSUTRO BIOPHARMA, INC. | 200,000 | $5.0M |
| IVVDInvivyd, Inc. | 3,661,480 | $4.8M |
| ASMBASSEMBLY BIOSCIENCES, INC. | 161,000 | $4.5M |
| ORICOric Pharmaceuticals, Inc. | 344,315 | $4.4M |
| OLMAOlema Pharmaceuticals, Inc. | 275,000 | $4.1M |
| ALXOALX ONCOLOGY HOLDINGS INC | 2,000,000 | $4.0M |
| IONSIONIS PHARMACEUTICALS INC | 50,000 | $3.8M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 400,000 | $3.6M |
| ANTXAN2 Therapeutics, Inc. | 1,000,000 | $3.4M |
| PGENPRECIGEN, INC. | 846,000 | $3.3M |
| PVLAPALVELLA THERAPEUTICS, INC. | 25,000 | $3.1M |
| CNTXContext Therapeutics Inc. | 1,000,000 | $2.6M |
| KRROKorro Bio, Inc. | 228,400 | $2.6M |
| SRZNSurrozen Inc. | 88,653 | $2.6M |
| NBPNovaBridge Biosciences | 1,000,000 | $2.5M |
| RNAAtrium Therapeutics Inc. | 183,580 | $2.5M |
| COGTCogent Biosciences, Inc. | 50,000 | $1.9M |
| ACETAdicet Bio, Inc. | 274,375 | $1.9M |
| ZVRAZEVRA THERAPEUTICS, INC. | 200,000 | $1.9M |
| PMNProMIS Neurosciences Inc. | 139,275 | $1.8M |
| CMPSCOMPASS Pathways plc | 300,000 | $1.7M |
| KTTAPasithea Therapeutics Corp. | 2,100,000 | $1.6M |
| IMUXIMMUNIC, INC. | 1,398,600 | $1.6M |
| INOINOVIO PHARMACEUTICALS, INC. | 804,958 | $1.4M |
| LRMRLarimar Therapeutics, Inc. | 300,000 | $1.4M |
| AARDAardvark Therapeutics, Inc. | 300,000 | $1.1M |
| IMAImageneBio, Inc. | 66,666 | $333K |
| ACADACADIA PHARMACEUTICALS INC | 10,000 | $223K |
| ENSCEnsysce Biosciences Inc. | 149,711 | $81K |